Crystal structure of Clostridium difficile toxin A

Nature Microbiology

Volumn 1, Issue 1, 2016, Pages

  Chumbler, Nicole M ^a   Rutherford, Stacey A ^a   Zhang, Zhifen ^b   Farrow, Melissa A ^a   Lisher, John P ^c   Farquhar, Erik ^d   Giedroc, David P ^c   Spiller, Benjamin W ^a   Melnyk, Roman A ^b   Lacy, D Borden ^a,e  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c INDIANA UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; ZINC; BACTERIAL TOXIN; ENTEROTOXIN; PROTEIN BINDING; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; HYDROPHOBICITY; MUTANT; PH; PRIORITY JOURNAL; STRUCTURE ANALYSIS; CHEMISTRY; COENZYME; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

BACTERIAL TOXINS; COENZYMES; CRYSTALLOGRAPHY, X-RAY; ENTEROTOXINS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; ZINC;

EID: 84965009684     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2015.2     Document Type: Article

References (45)

1. Lyerly, D. M., Krivan, H. C. &Wilkins, T. D. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1, 1-18 (1988).
2. Kelly, C. P. & LaMont, J. T. Clostridium difficile-more difficult than ever. N. Engl. J. Med. 359, 1932-1940 (2008).
3. Voth, D. E. & Ballard, J. D. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18, 247-263 (2005).
4. Jank, T. & Aktories, K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16, 222-229 (2008).
5. Lessa, F. C. et al. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825-834 (2015).
6. Lowy, I. et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N. Engl. J. Med. 362, 197-205 (2010).
7. Frey, S. M. & Wilkins, T. D. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect. Immun. 60, 2488-2492 (1992).
8. Orth, P. et al. Mechanism of action and epitopes of Clostridium difficile toxin Bneutralizing antibody bezlotoxumab revealed by X-ray crystallography. J. Biol. Chem. 289, 18008-18021 (2014).
9. Sauerborn, M., Leukel, P. & von Eichel-Streiber, C. The C-terminal ligandbinding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol. Lett. 155, 45-54 (1997).
10. Frisch, C., Gerhard, R., Aktories, K., Hofmann, F. & Just, I. The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem. Biophys. Res. Commun. 300, 706-711 (2003).
11. Florin, I. & Thelestam, M. Lysosomal involvement in cellular intoxication with Clostridium difficile toxin B. Microb. Pathog. 1, 373-385 (1986).
12. Qa'Dan, M., Spyres, L. M. & Ballard, J. D. pH-induced conformational changes in Clostridium difficile toxin B. Infect. Immun. 68, 2470-2474 (2000).
13. Barth, H. et al. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 276, 10670-10676 (2001).
14. Just, I. et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J. Biol. Chem. 270, 13932-13936 (1995).
15. Just, I. et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375, 500-503 (1995).
16. Egerer, M., Giesemann, T., Jank, T., Satchell, K. J. & Aktories, K. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity. J. Biol. Chem. 282, 25314-25321 (2007).
17. Reineke, J. et al. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446, 415-419 (2007).
18. Pruitt, R. N., Chambers, M. G., Ng, K. K., Ohi, M. D. & Lacy, D. B. Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc. Natl Acad. Sci. USA 107, 13467-13472 (2010).
19. Albesa-Jove, D. et al. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J. Mol. Biol. 396, 1260-1270 (2010).
20. Ho, J. G., Greco, A., Rupnik, M. & Ng, K. K. Crystal structure of receptorbinding C-terminal repeats from Clostridium difficile toxin A. Proc. Natl Acad. Sci. USA 102, 18373-18378 (2005).
21. Murase, T. et al. Structural basis for antibody recognition in the receptor-binding domains of toxins A and B from Clostridium difficile. J. Biol. Chem. 289, 2331-2343 (2014).
22. Olling, A. et al. The combined repetitive oligopeptides of Clostridium difficile toxin A counteract premature cleavage of the glucosyl-transferase domain by stabilizing protein conformation. Toxins (Basel) 6, 2162-2176 (2014).
23. Zhang, Y., Hamza, T., Gao, S. & Feng, H. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides. Biochem. Biophys. Res. Commun. 459, 259-263 (2015).
24. Jank, T., Giesemann, T. & Aktories, K. Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding. J. Biol. Chem. 282, 35222-35231 (2007).
25. Pruitt, R. N. et al. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity. J. Biol. Chem. 287, 8013-8020 (2012).
26. Rupnik, M. et al. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151, 199-208 (2005).
27. Kreimeyer, I. et al. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A. Naunyn Schmiedebergs Arch. Pharmacol. 383, 253-262 (2011).
28. Pruitt, R. N. et al. Structure-function analysis of inositol hexakisphosphateinduced autoprocessing in Clostridium difficile toxin A. J. Biol. Chem. 284, 21934-21940 (2009).
29. Puri, A. W. et al. Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB. Chem. Biol. 17, 1201-1211 (2010).
30. Shen, A. et al. Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins. Nature Struct. Mol. Biol. 18, 364-371 (2011).
31. von Eichel-Streiber, C., Laufenberg-Feldmann, R., Sartingen, S., Schulze, J. & Sauerborn, M. Comparative sequence analysis of the Clostridium difficile toxins A and B. Mol. Gen. Genet. 233, 260-268 (1992).
32. Zhang, Z. et al. Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore. Proc. Natl Acad. Sci. USA 111, 3721-3726 (2014).
33. Genisyuerek, S. et al. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B. Mol. Microbiol. 79, 1643-1654 (2011).
34. Choe, S. et al. The crystal structure of diphtheria toxin. Nature 357, 216-222 (1992).
35. Wang, J. & London, E. The membrane topography of the diphtheria toxin T domain linked to the a chain reveals a transient transmembrane hairpin and potential translocation mechanisms. Biochemistry 48, 10446-10456 (2009).
36. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004).
37. Teichert, M., Tatge, H., Schoentaube, J., Just, I. & Gerhard, R. Application of mutated Clostridium difficile toxin A for determination of glucosyltransferasedependent effects. Infect. Immun. 74, 6006-6010 (2006).
38. Chumbler, N. M. et al. Clostridium difficile toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathogens 8, e1003072 (2012).
39. Kabsch, W. XDS. Acta Crystallogr. D 66, 125-132 (2010).
40. Otwinowski, Z. & Minor, W. in Methods in Enzymology Vol. 276: Macromolecular Crystallography, part A (eds Carter, C. W. Jr & Sweets, R. M.) 307-326 (Academic, 1997).
41. Bricogne, G., Vonrhein, C., Flensburg, C., Schiltz, M. & Paciorek,W. Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0. Acta Crystallogr. D 59, 2023-2030 (2003).
42. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
43. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 60, 2126-2132 (2004).
44. Ravel, B. & Newville, M. ATHENA, ARTEMIS, HEPHAESTUS: data analysis for X-ray absorption spectroscopy using IFEFFIT. J. Synchrotron Radiat. 12, 537-541 (2005).
45. Schneider, C. A., Rasband,W. S. & Eliceiri, K.W. NIH image to ImageJ: 25 years of image analysis. Nature Methods 9, 671-675 (2012).